Clinical Trial Update: A Study of the Comparable Efficacy and Safety of Pulmozyme (Dornase Alfa) Delivered by the eRapid Nebulizer System in Patients With Cystic Fibrosis [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating whether Pulmozyme delivered by the eRapid Nebulizer System has comparable efficacy and safety to standard delivery in cystic fibrosis p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Pulmozyme (dornase alfa)

Snippet

Sponsor: Genentech, Inc. | Conditions: Cystic Fibrosis | Phase 4 | Status: COMPLETED | Results posted: 2014-05-01